 The outcome of clinical studies for vabicaserin may reveal whether 5-HT2C receptors can be possible targets for the treatment of schizophrenia.Aripiprazole is also a mild partial agonist of 5HT2C receptor.Activation of 5-HT2C receptor subtype has been reported to mediate numerous effects, such as penile erection.